Precision Genomics Medicine Biobank
NCT04187729 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100000
Last updated 2022-04-20
Summary
The immediate goal of this study is to collect biological samples (i.e., tissue and/or fluid), clinical information, and laboratory data from disease and non-disease subjects seen at Intermountain Healthcare affiliated facilities. The long-term goal is to annotate tissue and/or fluid biomarker data to clinical information and laboratory data for the purpose of improving health care delivery and prognostic potential.
Conditions
- Any Disease Condition and Reportedly-healthy Subjects
Sponsors & Collaborators
-
Intermountain Health Care, Inc.
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-24
- Primary Completion
- 2067-10-24
- Completion
- 2077-10-24
Countries
- United States
Study Locations
More Related Trials
-
Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.
NCT01079429 ·Status: TERMINATED
-
Decipher Genomics Resource for Intelligent Discovery
NCT02609269 ·Status: ENROLLING_BY_INVITATION
-
Specimen Collection from Patients with Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay
NCT02586389 ·Status: RECRUITING
-
Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies
NCT03762733 ·Status: ENROLLING_BY_INVITATION
-
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
NCT02090530 ·Status: RECRUITING
-
Clinical Study of Pan-cancer DNA Methylation Test in Plasma
NCT05685524 ·Status: UNKNOWN
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
NCT05334069 ·Status: RECRUITING
-
Clinical Sequencing Project for Metastatic Cancer Patients for Personalized Cancer Clinic.
NCT02593578 ·Status: UNKNOWN
-
Biomarkers in Tissue Samples From Patients With Hodgkin Lymphoma Enrolled on ECOG-2496 Clinical Trial
NCT01505712 ·Status: COMPLETED
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
NCT02726750 ·Status: RECRUITING
-
ctDNA Methylation Sequencing for Myeloma
NCT05578625 ·Status: UNKNOWN
-
Multi Institutional Study in Patient Presenting With Hematuria
NCT03122964 ·Status: UNKNOWN
-
Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
NCT01831609 ·Status: UNKNOWN
-
Vincere Biobank Research Protocol
NCT05954299 ·Status: RECRUITING
-
Gene Expression Monitoring of Mononuclear Cells (MNC) Subpopulations and Immunological Status and Metabolome Defining of Healthy Population
NCT01052649 ·Status: COMPLETED
-
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
NCT05366881 ·Status: RECRUITING
-
Genome-wide Association Study to Predict Treatment Response for Molecular Targeted Therapy in Hepatocellular Carcinoma and Renal Cell Carcinoma
NCT01482520 ·Status: COMPLETED
-
Detection Evaluation of a Novel Blood-based DNA Methylation Assay in Early-stage Hepatocellular Carcinoma Patients
NCT05343832 ·Status: UNKNOWN
-
Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease
NCT02612350 ·Status: COMPLETED
-
A Multicenter Cancer Biospecimen Collection Study
NCT04510129 ·Status: RECRUITING
-
Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)
NCT05736523 ·Status: ACTIVE_NOT_RECRUITING
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Genomic Profiling in Cancer Patients
NCT01775072 ·Status: RECRUITING
-
Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics
NCT06083779 ·Status: UNKNOWN